Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
My prayers are with your family. I was diagnosed with stage 3 more than two years ago and I've been in remission two years as of December 17th. Nothing is impossible. Keep the faith.
My cousin has just found out she has stage 4 Non-Hodgkin's lymphoma. She has 7 kids, most of whom are in their teens and a baby.
Prayers for my cousin would be appreciated... She is only 41.
My prayers are with your family. I was diagnosed with stage 3 more than two years ago and I've been in remission two years as of December 17th. Nothing is impossible. Keep the faith.
A nanoparticle with a heart of gold could end up being enemy number one for lymphoma, and perhaps other types of cancer. A new study shows that synthetic HDL nanoparticles with gold at their core can kill B-cell lymphoma, the most common form of lymphoma, in cultured human cells. The study, conducted by C. Shad Thaxton, M.D. and Leo I. Gordon, M.D., both of Northwestern Universitys Feinberg School of Medicine, also showed that the nanoparticles inhibited B-cell lymphoma tumor growth in mice.
The concept behind the science works like this: Lymphoma cells love to eat
cholesterol delivered to the cell by HDL. When the cells attach to the synthetic HDL nanoparticles, thinking theyre going to tuck into a big meal, the trap is sprung. The spongy surface of the nanoparticle sucks cholesterol out of the lymphoma cell and, in a devastating blow, the gold nanoparticle core prevents the cancer cell from acquiring the cholesterol-rich meal at the core of natural HDLs, thus starving it to death. This could mean future victims of lymphoma may be spared agonizing chemotherapy commonly administered today.
When the particle has done its job, Thaxton said, preliminary data in mice show that the nanoparticles appears to be metabolized through the liver, and eventually passed out through feces. The notion of using the nanoparticle to fight cancer was born of pure luck. In 2010, Thaxton, who originally intended for the nanoparticle to be used against heart disease, was giving a lecture on his project. Gordon, a professor of hematology/oncology was in the audience. Gordon knew that patients with advanced forms of B-cell lymphoma sometimes show decreasing levels of cholesterol. He contacted Thaxton and they began to collaborate.
MORE